Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,873 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00641706 | Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT01899066 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | unknown | Phase 2 | 20 | Sun Yat-sen UniversityOTHER | 1 | May 13, 2014 | clinicaltrials |
| NCT00121420 |
| Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases |
| terminated |
| Phase 2 |
| 45 |
| Pharmacyclics LLC.INDUSTRY |
| 2 |
| May 9, 2014 |
| clinicaltrials |
| NCT00492089 | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT01756989 | ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors | completed | Phase 2 | 50 | Helsinki University Central HospitalOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT00597402 | Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas | completed | Phase 2 | 125 | Duke UniversityOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT00677716 | Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse | completed | Phase 2 | 41 | Peregrine PharmaceuticalsINDUSTRY | 2 | Apr 24, 2014 | clinicaltrials |
| NCT00397072 | Epothilone in Recurrent Glioblastoma Patients | completed | Phase 2 | 15 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT00636805 | Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab | terminated | Phase 2 | 63 | Duke UniversityOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT01403311 | A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain(ALA) | unknown | Phase 2 | 18 | Legacy Health SystemOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00979017 | Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme | completed | Phase 2 | 41 | Katy PetersOTHER | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00657267 | Dose-Intense Temozolomide in Recurrent Glioblastoma | completed | Phase 2 | 58 | Patrick Y. Wen, MDOTHER | 1 | Mar 14, 2014 | clinicaltrials |
| NCT00611325 | Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma | completed | Phase 2 | 56 | Duke UniversityOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00337883 | A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme) | completed | Phase 2 | 110 | Genentech, Inc.INDUSTRY | 0 | Mar 4, 2014 | clinicaltrials |
| NCT01778088 | Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma | withdrawn | Phase 2 | 0 | Cellectar Biosciences, Inc.INDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01348607 | Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy | terminated | Phase 2 | 1 | University of South FloridaOTHER | 0 | Feb 21, 2014 | clinicaltrials |
| NCT01516983 | Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | completed | Phase 1 / Phase 2 | 15 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00017368 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | completed | Phase 2 | 42 | Children's Oncology GroupNETWORK | 2 | Feb 13, 2014 | clinicaltrials |
| NCT01118377 | A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Feb 6, 2014 | clinicaltrials |
| NCT01169116 | Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis | withdrawn | Phase 2 | 0 | Barretos Cancer HospitalOTHER | 1 | Feb 4, 2014 | clinicaltrials |
| NCT00066248 | Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment | completed | Phase 2 | 70 | University of South FloridaOTHER | 3 | Feb 3, 2014 | clinicaltrials |
| NCT02050243 | The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors(5-ALA) | unknown | Phase 1 / Phase 2 | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jan 30, 2014 | clinicaltrials |
| NCT00084695 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | unknown | Phase 2 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01600742 | Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis | terminated | Phase 2 | 4 | National Taiwan University HospitalOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00297024 | Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study) | completed | Phase 2 | 14 | University Health Network, TorontoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00575887 | Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma | completed | Phase 2 | 25 | Marmara UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00002803 | Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma | completed | Phase 2 | 44 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00025324 | Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors | unknown | Phase 2 | — | Children's Hospital Los AngelesOTHER | 3 | Dec 18, 2013 | clinicaltrials |
| NCT01400958 | Nuvigil or Placebo in Newly Diagnosed Malignant Glioma | terminated | Phase 2 | 6 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT01460706 | Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT(DOTAGLI) | completed | Phase 2 / Phase 3 | 30 | Turku University HospitalOTHER_GOV | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00107471 | Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma | terminated | Phase 1 / Phase 2 | 7 | Children's Oncology GroupNETWORK | 4 | Dec 10, 2013 | clinicaltrials |
| NCT00921167 | A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas | completed | Phase 2 | 32 | Clinical Research Center for Solid Tumor, KoreaOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00431561 | Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma | completed | Phase 2 | 141 | Isarna Therapeutics GmbHINDUSTRY | 6 | Dec 3, 2013 | clinicaltrials |
| NCT01342237 | Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors | unknown | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | Nov 19, 2013 | clinicaltrials |
| NCT01985451 | Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL） | unknown | Phase 2 | 15 | Rongjie TaoOTHER | 0 | Nov 15, 2013 | clinicaltrials |
| NCT01640509 | Synchrotron Radiation to the Treatment of Intracranial Tumors(ESRF) | unknown | Phase 1 / Phase 2 | 50 | University Hospital, GrenobleOTHER | 1 | Nov 11, 2013 | clinicaltrials |
| NCT00003292 | S9624 Ifosfamide in Treating Patients With Meningeal Tumors | terminated | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 4 | Nov 8, 2013 | clinicaltrials |
| NCT01203618 | Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas | withdrawn | Phase 2 | 0 | MorphotekINDUSTRY | 1 | Nov 4, 2013 | clinicaltrials |
| NCT00004110 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00919737 | Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme | completed | Phase 1 / Phase 2 | 24 | NobelpharmaINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01818713 | Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases | unknown | Phase 2 | 6 | The Netherlands Cancer InstituteOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT00053326 | Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00070525 | Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00281905 | Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | unknown | Phase 2 | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00416559 | Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only | unknown | Phase 2 | 140 | Children's Cancer and Leukaemia GroupOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00003743 | Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation | unknown | Phase 2 | 25 | St. Anna KinderkrebsforschungOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 14, 2014source: clinicaltrials